Literature DB >> 14985387

Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder.

S Papiol, A Rosa, B Gutiérrez, B Martín, P Salgado, R Catalán, B Arias, L Fañanás.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14985387      PMCID： PMC1735684          DOI： 10.1136/jmg.2003.012914

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  15 in total

1.  Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry.

Authors:  Vicente Molina; Gemma Galindo; Benjamín Cortés; Alba G Seco de Herrera; Ana Ledo; Javier Sanz; Carlos Montes; Juan A Hernández-Tamames
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-28       Impact factor: 5.270

Review 2.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

Review 3.  Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes?

Authors:  Wolfgang Maier; Barbara Höfgen; Astrid Zobel; Marcella Rietschel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

Review 4.  Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.

Authors:  Joanna K Soczynska; Sidney H Kennedy; Hanna O Woldeyohannes; Samantha S Liauw; Mohammad Alsuwaidan; Christina Y Yim; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2010-12-17       Impact factor: 3.843

5.  Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder.

Authors:  Johan Söderlund; Sara K Olsson; Martin Samuelsson; Lilian Walther-Jallow; Christian Johansson; Sophie Erhardt; Mikael Landén; Göran Engberg
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

6.  Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia.

Authors:  Kari Hänninen; Heikki Katila; Marika Saarela; Riikka Rontu; Kari M Mattila; Meng Fan; Mikko Hurme; Terho Lehtimäki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-09-27       Impact factor: 5.270

Review 7.  Evidence for a dysregulated immune system in the etiology of psychiatric disorders.

Authors:  Sinead M Gibney; Hemmo A Drexhage
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-05       Impact factor: 4.147

8.  Interleukin-1beta promoter (-31T/C and -511C/T) polymorphisms in major recurrent depression.

Authors:  Paulina Borkowska; Krzysztof Kucia; Szymon Rzezniczek; Monika Paul-Samojedny; Malgorzata Kowalczyk; Aleksander Owczarek; Renata Suchanek; Tomasz Medrala; Jan Kowalski
Journal:  J Mol Neurosci       Date:  2011-04-05       Impact factor: 3.444

9.  Activation of brain interleukin-1beta in schizophrenia.

Authors:  J Söderlund; J Schröder; C Nordin; M Samuelsson; L Walther-Jallow; H Karlsson; S Erhardt; G Engberg
Journal:  Mol Psychiatry       Date:  2009-12       Impact factor: 15.992

10.  An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study.

Authors:  Benjamin D Brown; Jérémie Nsengimana; Jennifer H Barrett; Richard A Lawrence; Lori Steiner; Suzanne Cheng; D Timothy Bishop; Nilesh J Samani; Stephen G Ball; Anthony J Balmforth; Alistair S Hall
Journal:  BMC Med       Date:  2010-01-13       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.